Back | Next |
home / stock / trib / trib message board
Subject | By | Source | When |
---|---|---|---|
Its better than 80 million release of new | HeilHiden | investorshub | 12/20/2021 2:50:47 PM |
Its a good deal to pay 8 million | StockLogistics | investorshub | 12/20/2021 2:21:07 PM |
600k a month | HeilHiden | investorshub | 12/20/2021 1:49:40 PM |
With over 100 million in revenues a year | HeilHiden | investorshub | 12/20/2021 1:47:29 PM |
Good deal all of it! | HeilHiden | investorshub | 12/20/2021 1:45:03 PM |
11% annual rate is more than 8 million | StockLogistics | investorshub | 12/20/2021 3:25:01 AM |
The Company and its subsidiaries entered into | StockLogistics | investorshub | 12/20/2021 3:24:01 AM |
Cant wait for Monday! | HeilHiden | investorshub | 12/18/2021 4:11:57 PM |
One buyer takes us up multiple cents. The | HeilHiden | investorshub | 12/17/2021 4:58:22 PM |
Current spread is 4 cents. 1.52 bid 1.56 ask | HeilHiden | investorshub | 12/17/2021 4:55:46 PM |
Ask is thin. Company restructuring debt for a | HeilHiden | investorshub | 12/17/2021 4:54:27 PM |
In connection with the Term Loan the Company | StockLogistics | investorshub | 12/17/2021 1:03:03 PM |
Saw it today! | HeilHiden | investorshub | 12/10/2021 3:08:45 PM |
The lower we go the more a buy | HeilHiden | investorshub | 12/08/2021 7:18:22 PM |
December 14 next chart opportunity imo, .68 cent | StockLogistics | investorshub | 12/06/2021 1:28:51 PM |
Value stock over perform during times of market | HeilHiden | investorshub | 11/29/2021 9:17:51 PM |
Its a value stock is why Im in | HeilHiden | investorshub | 11/29/2021 9:16:37 PM |
Six month consolidation ends today, should have news | StockLogistics | investorshub | 11/29/2021 1:02:26 PM |
There is a gap at .68 cents and | StockLogistics | investorshub | 11/29/2021 12:39:06 PM |
Lets rolllll | HeilHiden | investorshub | 11/26/2021 2:44:38 PM |
News, Short Squeeze, Breakout and More Instantly...
Trinity Biotech plc Company Name:
TRIB Stock Symbol:
NASDAQ Market:
DUBLIN, Ireland, April 04, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors, today announced results for the quarter ended December 31, 2023 and fisca...
DUBLIN, Ireland, March 28, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB) (the "Company"), a leading developer and manufacturer of d...
DUBLIN, Ireland, March 28, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, will report financial results for the fourth quarter and fiscal...